Hans H Maurer (H H Maurer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 11

Top Venues

Drug testing and analysis

Analytical chemistry

Clinical pharmacology and therapeutics

Universität des Saarlandes - Campus Homburg

Universität des Saarlandes - Campus Homburg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität des Saarlandes - Campus Homburg

Germany

Prof. Dr. Dr. h.c. :: Exper. & Clin. Toxicology

Education History

Universität des Saarlandes - Campus Homburg

Germany

PHD :: Exper. & Clin. Toxicology

Publications

Hans H Maurer
Pitfalls in drug testing by hyphenated low- and high-resolution mass spectrometry. Drug testing and analysis 12 (2) (2020)
Lea Wagmann, Simon D Brandt, Alexander Stratford, Hans H Maurer, Markus R Meyer
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug testing and analysis 11 (2) (2018)
Sascha K Manier, Lilian H J Richter, Jan Schäper, Hans H Maurer, Markus R Meyer
Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse. Drug testing and analysis (2018)
Lilian H J Richter, Hans H Maurer, Markus R Meyer
Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry. Drug testing and analysis 11 (2) (2018)
Madeleine Pettersson Bergstrand, Lilian H J Richter, Hans H Maurer, Lea Wagmann, Markus R Meyer
In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases. Drug testing and analysis 11 (1) (2018)
Achim T Caspar, Markus R Meyer, Hans H Maurer
Blood plasma level determination using an automated LC-MSn screening system and electronically stored calibrations exemplified for 22 drugs and two active metabolites often requested in emergency toxicology. Drug testing and analysis 11 (1) (2018)
Achim T Caspar, Jonas B Gaab, Julian A Michely, Simon D Brandt, Markus R Meyer, Hans H Maurer
Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS. Drug testing and analysis 10 (1) (2017)
Antje Blank, A Eidam, M Haag, N Hohmann, J Burhenne, M Schwab, Sfj van de Graaf, M R Meyer, Hans H Maurer, K Meier, J Weiss, T Bruckner, A Alexandrov, S Urban, G Mikus, W E Haefeli
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics. Clinical pharmacology and therapeutics 103 (2) (2017)
Julian A Michely, Hans H Maurer
A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration. Drug testing and analysis 10 (1) (2017)
Julian A Michely, Markus R Meyer, Hans H Maurer
Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MSn or GC-MS procedures. Drug testing and analysis 10 (1) (2017)
Julian A Michely, Markus R Meyer, Hans H Maurer
Paper Spray Ionization Coupled to High Resolution Tandem Mass Spectrometry for Comprehensive Urine Drug Testing in Comparison to Liquid Chromatography-Coupled Techniques after Urine Precipitation or Dried Urine Spot Workup. Analytical chemistry 89 (21) (2017)

Hans H Maurer.css-eqlu8i{font-size:small;padding-left:4px;} (H H Maurer)

Publication Activity (10 Years)

Top Topics

Top Venues

Hans H Maurer (H H Maurer)